Cigna’s Bradbury Talks PCSK9 Contracts And Value Versus Volume
This article was originally published in The Pink Sheet Daily
Executive Summary
Amgen and Sanofi/Regeneron will pay deeper discounts if patients taking Repatha and Praluent don’t experience similar levels of LDL-cholesterol lowering as was seen in clinical trials.